I tried an anti-ageing guru's ‘fake fasting' plan. Did it work?
It's day one of my five-day fast and I'm serving up food I can't eat. It's typical that today of all days I'd make the best pasta I've ever made. 'I think this is the best pasta you've ever made,' says my partner, confirming my suspicions. 'Oh really?' I mutter, averting my eyes as everyone enthusiastically tucks in.
How have I got myself into this predicament? A scheduling error. It turns out that finding a whole working week to go without food isn't all that easy.
Fasting has become mainstream in recent years, and studies suggest it can be good for everything, from weight loss and better heart health, to reducing inflammation, enhancing brain function and improving the gut microbiome.
But the most fascinating thing
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
17 minutes ago
- Daily Mail
EXCLUSIVE Warning over hair loss cream used by millions after doctors discover freaky side effect
Doctors have issued a warning about hair growth treatment minoxidil after a woman grew a beard. The 28-year-old reported using hair growth spray minoxidil to treat her hair loss caused by alopecia, suffered by 7million Americans that causes hair loss. Patients apply the medication, sold as a spray or foam, to the scalp and leave it in to absorb. However, the unnamed woman wore a wig during the day and cap at night, which causes the drug to be absorbed at much higher levels in her blood. It then traveled elsewhere in her body, causing uncontrollable hair growth in her face, arms and legs. Doctors say the 40million Americans who take the drug should be aware of the risks of wearing tight caps while taking it. Minoxidil, sold in the US under brand name Rogaine, is applied to the scalp to stimulate hair growth. It costs around $60 for a six-month supply. Doctors writing in as medical journal said: 'Exceeding this dose does not improve efficacy but significantly increases the risk of systemic absorption and adverse effects.' The FDA approved safe dose of the spray, which the woman used, is one milliter twice per day, or six sprays. While side effects are usually minor, such as scalp irritation or changes in hair texture or color, the drug has been linked to excess hair growth and loss. The woman in the case report was diagnosed with androgenetic alopecia, a form of hair loss caused by genetic predisposition or an imbalance of hormones like estrogen and androgens. Prior to treatment, the woman, from France, had a large bald spot on the top of her head. She had mild anemia and vitamin D, both of which can deprive hair follicles of oxygen and cause hair loss, but had no other health issues. Along with vitamin D and zinc supplements, she used five percent minoxidil spray twice a day for two months. She also had done three monthly sessions of LED therapy and plasma-rich plasma injections (PRP), which are meant to separate plasma from the blood and inject it back into the scalp. Plasma is rich in platelets, which have growth factors. After two months of minoxidil treatment, she returned to doctors with increased hair growth on her face, arms and legs. Doctors found wearing a wig during the day and a tight cap at night after applying minoxidil left the woman's scalp 'constantly occluded, day and night.' This means her scalp was constricted and hair follicles became blocked, leading the body to absorb higher amounts of minoxidil than if her hair follicles were still open. The doctors believe this lead to 'systemic absorption' of the drug and effectively a higher than safe dose. The experts wrote: 'Minoxidil is an effective treatment but can occasionally lead to hypertrichosis, especially when applied in high concentrations or over large areas of the body. 'This case illustrates the critical need for precise patient instruction on the correct application of topical therapies to prevent adverse systemic effects such as hypertrichosis.' The woman had laser hair removal on her face and stopped taking minoxidil. She continued with her other treatments.
Reuters
20 minutes ago
- Reuters
Vaccine actions and policy positions under US Health Secretary Kennedy
June 10 (Reuters) - U.S. Health Secretary Robert F. Kennedy Jr., a long-time vaccine skeptic, has been making sweeping changes to reshape U.S. regulation of vaccines, food and medicine. The most far-reaching of his moves culminated in the layoff of all 17 members of a U.S. Centers for Disease Control and Prevention panel of vaccine experts. Here are some of the policy moves under Kennedy's leadership in recent months, related to vaccines: FDA Recommendations for Influenza Vaccines Date of Announcement: March 13, 2025 Details: The FDA independently recommends virus strains for the 2025-2026 influenza vaccines, deviating from traditional advisory committee voting. This move assures no impact on the timing or availability of vaccines for the public. Environmental Toxin Studies Related to Autism Date of Announcement: April 16, 2025 Details: Kennedy plans studies on environmental contributors to autism, including vaccines, despite lacking scientific evidence. This approach aligns with his longstanding views on vaccines and environmental factors. Launch of US Autism Project Using Medicare and Medicaid Data Date of Announcement: May 7, 2025 Details: Federal agencies will create a database to research autism causes, focusing on Medicare and Medicaid data, as part of a broader effort to explore potential links between vaccines and autism. FDA Tightens Requirements for COVID Vaccine Date of Announcement: May 20, 2025 Details: The FDA plans new trials for annual COVID-19 boosters, limiting them to older adults and those at risk of severe illness. This change aligns with international perspectives on COVID vaccination strategies. US Drops COVID Vaccine Recommendation for Healthy Kids, Pregnant Women Date of Announcement: May 27, 2025 Details: The U.S. stops recommending routine COVID vaccinations for pregnant women and healthy children, bypassing the CDC's traditional advisory process. Cancellation of Moderna Bird Flu Vaccine Contract Date of Announcement: May 28, 2025 Details: The Trump administration cancels a contract with Moderna for the late-stage development of its bird flu vaccine, after determining it did not meet scientific standards. Moderna explores alternatives for its vaccine's development. Kennedy Guts Vaccine Advisory Committee Date of Announcement: June 9, 2025 Details: Kennedy fires all members of the CDC vaccine expert panel, which recommends how vaccines are used and by whom, promising to restore public trust in health agencies. Scientists and experts say the changes would undermine public confidence in health agencies.
The Independent
an hour ago
- The Independent
Rare cancer with nonspecific symptoms increasing among millennials
A study published in Annals of Internal Medicine indicates a surprising increase in appendix cancer rates among Millennials and Generation X, suggesting a higher disease burden in younger generations. The study assessed data from 4,858 patients diagnosed with appendix cancer between 1975 and 2019, categorising them into five-year age groups to understand how the risk evolved over the years. Compared to the 1945 birth cohort, the incidence of appendix cancer more than tripled in individuals born around 1980 and quadrupled by the birth cohort of 1985. Researchers suggest that environmental, lifestyle, and genetic factors intensified after World War II, such as dietary patterns, gut bacteria alterations, and gastrointestinal inflammation, may explain the increase. The study calls for more research, particularly involving genomics data, to uncover the mechanisms driving this trend and urges physicians to revisit screening protocols and develop early detection biomarkers.
